Merrimack Pharma (MACK) trading halted with news pending
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Merrimack Pharma (NASDAQ: MACK) trading halted with news pending.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merrimack Pharma (MACK) Appoints Richard Peters President and CEO
- Pulmatrix (PULM) Halted on LUDP, Shares Up 105%
- Pulmatrix (PULM) Halted Again on LUDP